“…It has been reported that the half-life of OTA in humans is approximately 35 days (Creppy et al, 1983;Hagelberg et al, 1989). In fact, OTA has been frequently found in human blood plasma (Bennett & Klich, 2003;Coronel et al, 2010;Medina et al, 2010), and its nephro-, hepato-, terato-and immunotoxic consequences have been reported (Arora et al, 1983;Harvey et al, 1992;Haubeck et al, 1981;Hope & Hope, 2012;Kuiper-Goodman, 1991;López de Cerain, 2007;Mortensen et al, 1983;Pfohl-Leszkowicz & Manderville, 2007;Wilk-Zasadna & Minta, 2009). In the last few years, OTA exposure studies have been developed on different cell lines of human and animal models, especially describing the mechanisms associated with increased levels of oxidative stress, DNA, lipid and protein damage (Bennett & Klich, 2003;Creppy et al, 1985b;Friedman & Rasooly, 2013;Gautier et al, 2001;Hibi et al, 2013;Hope & Hope, 2012;Kumar et al, 2012;Marin-Kuan et al, 2011;Sava et al, 2006aSava et al, ,2006b.…”